Shanghai Medicilon Inc (688202) — Tangible Net Worth Ratio
Shanghai Medicilon Inc (688202) has a Tangible Net Worth Ratio of 86.4% as of March 2026. This metric is calculated by deducting intangible assets (CN¥266.88 Million) from net assets (CN¥1.96 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Shanghai Medicilon Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Shanghai Medicilon Inc Tangible Net Worth Ratio (2016–2025)
This chart shows how Shanghai Medicilon Inc's Tangible Net Worth Ratio has changed across 10 annual periods from 2016 to 2025. As of March 2026, the ratio stands at 86.4%, reflecting net assets of CN¥1.96 Billion with intangible assets of CN¥266.88 Million CNY. See Shanghai Medicilon Inc (688202) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Shanghai Medicilon Inc (2016–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Shanghai Medicilon Inc from 2016 to 2025, covering 10 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Shanghai Medicilon Inc (688202) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 86.1% | CN¥1.93 Billion | CN¥269.20 Million | CN¥2.62 Billion | ▼ -0.9 pp |
| 2024 | 87.0% | CN¥2.14 Billion | CN¥278.15 Million | CN¥2.82 Billion | ▼ -1.6 pp |
| 2023 | 88.6% | CN¥2.51 Billion | CN¥286.90 Million | CN¥3.27 Billion | ▲ +6.9 pp |
| 2022 | 81.7% | CN¥1.60 Billion | CN¥294.05 Million | CN¥2.33 Billion | ▼ -0.9 pp |
| 2021 | 82.6% | CN¥1.33 Billion | CN¥231.61 Million | CN¥1.79 Billion | ▲ +3.2 pp |
| 2020 | 79.3% | CN¥1.14 Billion | CN¥235.02 Million | CN¥1.36 Billion | ▼ -20.2 pp |
| 2019 | 99.5% | CN¥1.00 Billion | CN¥4.91 Million | CN¥1.13 Billion | ▲ +0.9 pp |
| 2018 | 98.6% | CN¥347.89 Million | CN¥4.74 Million | CN¥472.95 Million | ▼ -1.0 pp |
| 2017 | 99.6% | CN¥287.32 Million | CN¥1.11 Million | CN¥389.61 Million | ▼ -0.2 pp |
| 2016 | 99.8% | CN¥246.09 Million | CN¥449.46K | CN¥344.90 Million | — |